HIV Mutation K70Q Increases Resistance to Tenofovir
Author Information
Author(s): Hachiya Atsuko, Kodama Eiichi N., Schuckmann Matthew M., Kirby Karen A., Michailidis Eleftherios, Sakagami Yasuko, Oka Shinichi, Singh Kamalendra, Sarafianos Stefan G.
Primary Institution: Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, Missouri, United States of America
Hypothesis
The K70Q mutation in the Q151M complex HIV-1 reverse transcriptase enhances resistance to tenofovir disoproxil fumarate.
Conclusion
The K70Q mutation significantly increases resistance to tenofovir in HIV-1 carrying the Q151M complex.
Supporting Evidence
- The K70Q mutation was identified in a clinical isolate from a patient treated with tenofovir.
- HIV-1 with K70Q showed significantly enhanced resistance to tenofovir compared to strains without this mutation.
- The study demonstrated that K70Q mutation affects the binding of tenofovir-diphosphate, reducing its incorporation into DNA.
Takeaway
A new mutation in HIV makes it harder for a medicine called tenofovir to work, which is important for treating people with HIV.
Methodology
The study used virological, biochemical, and molecular modeling methods to analyze the effects of the K70Q mutation on drug resistance.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website